Abstract:BACKGROUND:Pancreatic cancer is a highly lethal disease and has the worst prognosis of any major malignancy. G protein-coupled receptor GPR87 is reported to be overexpressed in multiple cancers. The clinical significance and biological role of GPR87 in pancreatic cancer, however, remain to be established.METHODS:GPR87 expression in pancreatic cancer cell lines, paired patient tissues were determined using western blotting and Real-time PCR. Ninety-six human pancreatic cancer tissue samples were analyzed by immunochemistry (IHC) to investigate the association between GPR87 expression and the clinicopathological characteristics of pancreatic cancer. Functional assays, such as anchorage-independent growth, chicken chorioallantoic membrane (CAM) assay, transwell matrix penetration assay, and Annexin V-FITC and PI staining and a xenograft tumor model were used to determine the oncogenic role of GPR87 in human pancreatic cancer progression. The effect of GPR87 on NF-κB signaling pathway was further investigated using the luciferase reporter assays, and by detection of the NF-κB signaling downstream genes.RESULTS:Herein, we reported that GPR87 was markedly overexpressed in pancreatic cancer cells and clinical tissues. Immunohistochemical analysis showed that the expression of GPR87 significantly correlated with patients' clinicopathologic features, including clinical stage and tumor-nodule-metastasis (TNM) classification. Pancreatic cancer patients with higher levels of GPR87 expression had shorter overall survival compared to patients with lower GPR87 levels. We gained valuable insights into the mechanism of GPR87 expression in pancreatic cancer cells by demonstrating that overexpressing GPR87 significantly enhanced, whereas silencing endogenous GPR87 inhibited, the proliferation, angiogenesis and increased resistance to gemcitabine-induced apoptosis of pancreatic cancer in vitro and tumorigenicity of pancreatic cancer cells in vivo. Finally, we demonstrated that GPR87 enhanced pancreatic cancer aggressiveness by activating NF-κB signaling pathway.CONCLUSIONS:Taken together, these findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy.CONCLUSIONS:Our findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy.

The Gene RAD51AP1 Promotes the Progression of Pancreatic Cancer Via the PI3K/Akt/NF-κB Signaling Pathway.

Activated K‐Ras and INK4a/Arf Deficiency Promote Aggressiveness of Pancreatic Cancer by Induction of EMT Consistent with Cancer Stem Cell Phenotype

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

TBL1XR1 Induces Cell Proliferation and Inhibit Cell Apoptosis by the PI3K/AKT Pathway in Pancreatic Ductal Adenocarcinoma.

Apoptosis Signal-Regulating Kinase 1 Exhibits Oncogenic Activity in Pancreatic Cancer

PKCι is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.

High Kpnβ1 Expression Promotes Non-Small Cell Lung Cancer Proliferation and Chemoresistance Via the PI3-kinase/AKT Pathway.

Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling

Oncogene APOL1 Promotes Proliferation and Inhibits Apoptosis Via Activating NOTCH1 Signaling Pathway in Pancreatic Cancer

Ott_a_223221 8287..8299

Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro

INPP4B As A Prognostic and Diagnostic Marker Regulates Cell Growth of Pancreatic Cancer Via Activating AKT

Hnrnpc Promotes Malignancy in Pancreatic Cancer Through Stabilization of IQGAP3

Profilin1 Sensitizes Pancreatic Cancer Cells to Irradiation by Inducing Apoptosis and Reducing Autophagy

Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer

The Biological Features of PanIN Initiated from Oncogenic Kras Mutation in Genetically Engineered Mouse Models

HNF-1a Promotes Pancreatic Cancer Growth and Apoptosis Resistance Via Its Target Gene PKLR.

N<SUP>6</SUP>-methyladenosine mRNA methylation of <i>PIK3CB</i> regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression

Decreased PANK1 expression in kidney renal clear cell carcinoma: impact on cell apoptosis, invasion, migration, and epithelial-mesenchymal transition

MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer

Overexpression of G Protein-Coupled Receptor GPR87 Promotes Pancreatic Cancer Aggressiveness and Activates NF-κB Signaling Pathway